You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diet, nutrition and obesity

Semaglutide 7.2 mg single-dose device for managing overweight and obesity [TSID12324]

  • Awaiting development
  • Reference number: GID-TA11920
  • Expected publication date: TBC
  • Project information
  • Project documents

40713-Semaglutide-for-Weight-Management-V1.0-OCT2025-NON-CONF.pdf

Back to top